Fingerprint
Dive into the research topics of 'CDK 4/6 Inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: Phase II activity, safety, and predictive biomarker assessment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically